Corient Capital Partners, LLC Eli Lilly & CO Transaction History

Corient Capital Partners, LLC

$1.34 Billion
Q3 2022

A detailed history of Corient Capital Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Corient Capital Partners, LLC holds 43,239 shares of LLY stock, worth $38 Million. This represents 1.05% of its overall portfolio holdings.

Number of Shares

43,239

Previous 43,239 -0.0%

Holding current value

$38 Million

Previous $14 Million -0.0%

% of portfolio

1.05%

Previous 1.06%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$278.73 - $327.27 $503,386 - $591,049	-1,806 Reduced 4.01%	43,239 $14 Million
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $488,624 - $607,236	2,082 Added 4.85%	45,045 $12.9 Million
Q4 2021 Feb 11, 2022	SELL	$224.85 - $279.04 $38,899 - $48,273	-173 Reduced 0.4%	42,963 $11.9 Million
Q3 2021 Nov 16, 2021	BUY	$221.6 - $272.71 $557,102 - $685,592	2,514 Added 6.19%	43,136 $9.97 Million
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $504,637 - $652,744	2,795 Added 7.39%	40,622 $9.32 Million
Q1 2021 May 17, 2021	SELL	$164.32 - $212.72 $863,008 - $1.12 Million	-5,252 Reduced 12.19%	37,827 $7.07 Million
Q4 2020 Feb 12, 2021	SELL	$130.46 - $172.63 $69,665 - $92,184	-534 Reduced 1.22%	43,079 $7.27 Million
Q3 2020 Nov 16, 2020	SELL	$146.22 - $169.13 $321,537 - $371,916	-2,199 Reduced 4.8%	43,613 $6.46 Million
Q2 2020 Aug 14, 2020	BUY	$136.42 - $164.18 $735,849 - $885,586	5,394 Added 13.35%	45,812 $7.52 Million
Q1 2020 May 06, 2020	BUY	$119.05 - $147.35 $1.05 Million - $1.3 Million	8,853 Added 28.05%	40,418 $5.61 Million
Q4 2019 Feb 04, 2020	BUY	$106.92 - $132.43 $269,438 - $333,723	2,520 Added 8.68%	31,565 $4.15 Million
Q3 2019 Nov 06, 2019	BUY	$106.79 - $116.16 $280,003 - $304,571	2,622 Added 9.92%	29,045 $3.25 Million
Q2 2019 Aug 08, 2019	SELL	$110.79 - $129.32 $324,393 - $378,648	-2,928 Reduced 9.98%	26,423 $2.93 Million
Q1 2019 May 10, 2019	BUY	$111.31 - $131.02 $230,300 - $271,080	2,069 Added 7.58%	29,351 $3.81 Million
Q4 2018 Feb 07, 2019	SELL	$105.9 - $118.64 $1.06 Million - $1.19 Million	-10,002 Reduced 26.83%	27,282 $3.16 Million
Q2 2018 Oct 02, 2018	SELL	$75.7 - $86.88 $1.39 Million - $1.59 Million	-18,330 Reduced 32.96%	37,284 $3.18 Million
Q1 2018 May 14, 2018	SELL	$74.21 - $87.6 $813,193 - $959,920	-10,958 Reduced 16.46%	55,614 $4.3 Million
Q4 2017 Feb 13, 2018	BUY	$81.94 - $87.89 $216,813 - $232,556	2,646 Added 4.14%	66,572 $5.62 Million
Q3 2017 Nov 14, 2017	SELL	$77.07 - $85.54 $1.46 Million - $1.62 Million	-18,900 Reduced 22.82%	63,926 $0
Q2 2017 Aug 14, 2017	SELL	N/A	-1,394 Reduced 1.66%	82,826 $6.82 Million
Q1 2017 Aug 17, 2017	BUY	N/A	71,103 Added 542.07%	84,220 $7.08 Million
Q1 2017 Aug 14, 2017	BUY	N/A	13,117	13,117 $2.15 Million

Others Institutions Holding LLY

# of Institutions

4,121

Shares Held

740M

Call Options Held

8.26M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $835B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Corient Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Corient Capital Partners, LLC with notifications on news.

Account

Corient Capital Partners, LLC Eli Lilly & CO Transaction History